Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

Index by author

July 01, 2011; Volume 78,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

C

  1. Castro, Mario

    1. Bronchial thermoplasty: A new treatment for severe refractory asthma
      You have access
      Bronchial thermoplasty: A new treatment for severe refractory asthma
      Thomas R. Gildea, MD, MS, Sumita B. Khatri, MD, MS and Mario Castro, MD, MPH
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 477-485; DOI: https://doi.org/10.3949/ccjm.78a.10185

      Asthma has a new treatment, but it isn’t for everybody. Here, we review its indications, evidence of efficacy, and protocols.

G

  1. Gildea, Thomas R.

    1. Bronchial thermoplasty: A new treatment for severe refractory asthma
      You have access
      Bronchial thermoplasty: A new treatment for severe refractory asthma
      Thomas R. Gildea, MD, MS, Sumita B. Khatri, MD, MS and Mario Castro, MD, MPH
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 477-485; DOI: https://doi.org/10.3949/ccjm.78a.10185

      Asthma has a new treatment, but it isn’t for everybody. Here, we review its indications, evidence of efficacy, and protocols.

H

  1. Hogarth, D. Kyle

    1. You have access
      Bronchial thermoplasty: A promising therapy, still in its infancy
      Amit K. Mahajan, MD and D. Kyle Hogarth, MD, FCCP
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 475-476; DOI: https://doi.org/10.3949/ccjm.78a.11063

      Inflammation is not the only pathophysiologic process underlying asthma. Bronchial thermoplasty takes a novel approach and offers reason for optimism.

I

  1. Induru, Raghava R.

    1. You have access
      Managing cancer pain: Frequently asked questions
      Raghava R. Induru, MD and Ruth L. Lagman, MD, MPH, FACP
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 449-464; DOI: https://doi.org/10.3949/ccjm.78a.10054

      Cancer pain: its pathogenesis, how to assess it, and how to treat it—in particular, how to use opioids optimally.

J

  1. Jaffer, Amir K.

    1. You have access
      Update in hospital medicine: Studies likely to affect inpatient practice in 2011
      Amir K. Jaffer, MD
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 430-434; DOI: https://doi.org/10.3949/ccjm.78gr.11002

      A hypothetical case scenario helps focus on anticoagulants, patient safety, quality improvement, critical care, transitions of care, and perioperative medicine.

K

  1. Khatri, Sumita B.

    1. Bronchial thermoplasty: A new treatment for severe refractory asthma
      You have access
      Bronchial thermoplasty: A new treatment for severe refractory asthma
      Thomas R. Gildea, MD, MS, Sumita B. Khatri, MD, MS and Mario Castro, MD, MPH
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 477-485; DOI: https://doi.org/10.3949/ccjm.78a.10185

      Asthma has a new treatment, but it isn’t for everybody. Here, we review its indications, evidence of efficacy, and protocols.

L

  1. Lagman, Ruth L.

    1. You have access
      Managing cancer pain: Frequently asked questions
      Raghava R. Induru, MD and Ruth L. Lagman, MD, MPH, FACP
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 449-464; DOI: https://doi.org/10.3949/ccjm.78a.10054

      Cancer pain: its pathogenesis, how to assess it, and how to treat it—in particular, how to use opioids optimally.

M

  1. Mahajan, Amit K.

    1. You have access
      Bronchial thermoplasty: A promising therapy, still in its infancy
      Amit K. Mahajan, MD and D. Kyle Hogarth, MD, FCCP
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 475-476; DOI: https://doi.org/10.3949/ccjm.78a.11063

      Inflammation is not the only pathophysiologic process underlying asthma. Bronchial thermoplasty takes a novel approach and offers reason for optimism.

  2. Mandell, Brian F.

    1. You have access
      When good drugs turn weirdly bad
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 426; DOI: https://doi.org/10.3949/ccjm.78b.11007

      Even the most specific of drugs, such as interferon, can have untoward biologic effects.

  3. Menon, Venu

    1. You have access
      Hypothermia after cardiac arrest: Beneficial, but slow to be adopted
      Santosh Samuel Oommen, MD and Venu Menon, MD
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 441-448; DOI: https://doi.org/10.3949/ccjm.78a.10157

      Survivors of cardiac arrest due to ventricular tachycardia or ventricular fi brillation have better neurologic outcomes if they are cooled to a core body temperature of 32°C to 34°C for 24 hours as soon as possible after reaching the hospital.

N

  1. Neuner, Elizabeth

    1. You have access
      Vancomycin: A 50-something-yearold antibiotic we still don’t understand
      Amy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MD
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168

      To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.

O

  1. Oommen, Santosh Samuel

    1. You have access
      Hypothermia after cardiac arrest: Beneficial, but slow to be adopted
      Santosh Samuel Oommen, MD and Venu Menon, MD
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 441-448; DOI: https://doi.org/10.3949/ccjm.78a.10157

      Survivors of cardiac arrest due to ventricular tachycardia or ventricular fi brillation have better neurologic outcomes if they are cooled to a core body temperature of 32°C to 34°C for 24 hours as soon as possible after reaching the hospital.

R

  1. Rehm, Susan J.

    1. You have access
      Vancomycin: A 50-something-yearold antibiotic we still don’t understand
      Amy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MD
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168

      To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.

S

  1. Schilling, Amy

    1. You have access
      Vancomycin: A 50-something-yearold antibiotic we still don’t understand
      Amy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MD
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168

      To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.

T

  1. Tang, Derek M.

    1. You have access
      Rash from hepatitis C treatment
      Derek M. Tang, MD and Lawrence Ward, MD, MPH
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 472-474; DOI: https://doi.org/10.3949/ccjm.78a.10124

      Although the combination of interferon and ribavirin is the standard of treatment for chronic hepatitis C, some patients experience adverse reactions.

W

  1. Ward, Lawrence

    1. You have access
      Rash from hepatitis C treatment
      Derek M. Tang, MD and Lawrence Ward, MD, MPH
      Cleveland Clinic Journal of Medicine July 2011, 78 (7) 472-474; DOI: https://doi.org/10.3949/ccjm.78a.10124

      Although the combination of interferon and ribavirin is the standard of treatment for chronic hepatitis C, some patients experience adverse reactions.

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 78 (7)
Cleveland Clinic Journal of Medicine
Vol. 78, Issue 7
1 Jul 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
Which ICU patients need stress ulcer prophylaxis?
Dactylitis from Mycobacterium intracellulare infection
Mondor disease of the breast
Dyspnea and cough in a lung transplant recipient
Atypical erythema as a clinical presentation of tinea incognito
Pigmented lesion on nail bed: Pseudo-Hutchinson sign
Hampton hump in acute pulmonary embolism
A brownish erythematous patch in the nipple-areola complex
The underappreciated role of documentation in improving COPD care
Oral hyperpigmentation with weakness and salt-craving
Glycemic targets in the ICU: A look back, and ahead
Unilateral pulmonary edema
Does my patient need an allergy evaluation for penicillin allergy?

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2022 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire